These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

249 related items for PubMed ID: 23169485

  • 1. Immunoparesis and monoclonal gammopathy of undetermined significance are disassociated in advanced age.
    Cherry BM, Costello R, Zingone A, Burris J, Korde N, Manasanch E, Kwok M, Annunziata C, Roschewski MJ, Engels EA, Landgren O.
    Am J Hematol; 2013 Feb; 88(2):89-92. PubMed ID: 23169485
    [Abstract] [Full Text] [Related]

  • 2. Prevalence and progression of monoclonal gammopathy of undetermined significance and light-chain MGUS in Germany.
    Eisele L, Dürig J, Hüttmann A, Dührsen U, Assert R, Bokhof B, Erbel R, Mann K, Jöckel KH, Moebus S, Heinz Nixdorf Recall Study Investigative Group.
    Ann Hematol; 2012 Feb; 91(2):243-8. PubMed ID: 21789623
    [Abstract] [Full Text] [Related]

  • 3. Prevalence and risk of progression of light-chain monoclonal gammopathy of undetermined significance: a retrospective population-based cohort study.
    Dispenzieri A, Katzmann JA, Kyle RA, Larson DR, Melton LJ, Colby CL, Therneau TM, Clark R, Kumar SK, Bradwell A, Fonseca R, Jelinek DF, Rajkumar SV.
    Lancet; 2010 May 15; 375(9727):1721-8. PubMed ID: 20472173
    [Abstract] [Full Text] [Related]

  • 4. Prevalence of monoclonal gammopathy of undetermined significance in an elderly urban Korean population.
    Park HK, Lee KR, Kim YJ, Cho HI, Eun Kim J, Woong Kim K, Jung Kim Y, Lee KW, Hyun Kim J, Bang SM, Lee JS.
    Am J Hematol; 2011 Sep 15; 86(9):752-5. PubMed ID: 21786289
    [Abstract] [Full Text] [Related]

  • 5. Multiple Myeloma and Its Precursor Disease Among Firefighters Exposed to the World Trade Center Disaster.
    Landgren O, Zeig-Owens R, Giricz O, Goldfarb D, Murata K, Thoren K, Ramanathan L, Hultcrantz M, Dogan A, Nwankwo G, Steidl U, Pradhan K, Hall CB, Cohen HW, Jaber N, Schwartz T, Crowley L, Crane M, Irby S, Webber MP, Verma A, Prezant DJ.
    JAMA Oncol; 2018 Jun 01; 4(6):821-827. PubMed ID: 29710195
    [Abstract] [Full Text] [Related]

  • 6. Monoclonal Gammopathy of Undetermined Significance (MGUS)Monoclonal Gammopathy of Undetermined Significance (MGUS).
    Viera S, Ludek P, Zdeněk A, Marta K, Martin Š, Sabina Š, Zdeněk K.
    Klin Onkol; 2018 Jun 01; 31(4):270-276. PubMed ID: 30541309
    [Abstract] [Full Text] [Related]

  • 7. [Monoclonal gammopathy of undetermined significance and evolution to myeloma: Experience in 153 patients].
    López Gómez JM, Sacristán Enciso B, Fernández-Cavada Pollo MJ, Bueno García V, Gómez Vera S.
    Semergen; 2021 Oct 01; 47(7):441-447. PubMed ID: 34479794
    [Abstract] [Full Text] [Related]

  • 8. [Analysis of serum levels of Dickkopf-1 (DKK-1) in monoclonal gammopathy of undetermined significance and multiple myeloma].
    Ščudla V, Petrová P, Pika T, Lochman P, Minařík J, Bačovský J, Srovnalík K.
    Cas Lek Cesk; 2015 Oct 01; 154(4):181-8. PubMed ID: 26357861
    [Abstract] [Full Text] [Related]

  • 9. Monoclonal gammopathy of undetermined significance and risk of lymphoid and myeloid malignancies: 728 cases followed up to 30 years in Sweden.
    Turesson I, Kovalchik SA, Pfeiffer RM, Kristinsson SY, Goldin LR, Drayson MT, Landgren O.
    Blood; 2014 Jan 16; 123(3):338-45. PubMed ID: 24222331
    [Abstract] [Full Text] [Related]

  • 10. Prevalence of monoclonal gammopathy of undetermined significance in Shenzhen, China.
    Xu A, Guo T, Zhang S, Luo H, Shen M, Ye Y, Ji L.
    Hematology; 2024 Dec 16; 29(1):2352686. PubMed ID: 38819332
    [Abstract] [Full Text] [Related]

  • 11. Increased prevalence of light chain monoclonal gammopathy of undetermined significance (LC-MGUS) in first-degree relatives of individuals with multiple myeloma.
    Greenberg AJ, Rajkumar SV, Larson DR, Dispenzieri A, Therneau TM, Colby CL, Phelps TK, Kumar SK, Katzmann JA, Kyle RA, Slager SL, Vachon CM.
    Br J Haematol; 2012 May 16; 157(4):472-5. PubMed ID: 22629552
    [Abstract] [Full Text] [Related]

  • 12. [The value of serum free light chain in differential diagnosis of monoclonal gammopathy of renal significance].
    Li C, Wen YB, Li H, Su W, Li J, Cai JF, Chen LM, Li XM, Li XW.
    Zhonghua Yi Xue Za Zhi; 2017 Aug 08; 97(30):2344-2348. PubMed ID: 28822451
    [Abstract] [Full Text] [Related]

  • 13. Prognostic Impact of Serum Heavy/Light Chain Pairs in Patients With Monoclonal Gammopathy of Undetermined Significance and Smoldering Myeloma: Long-Term Results From a Single Institution.
    Magnano L, Fernández de Larrea C, Elena M, Cibeira MT, Tovar N, Aróstegui JI, Pedrosa F, Rosiñol L, Filella X, Yagüe J, Bladé J.
    Clin Lymphoma Myeloma Leuk; 2016 Jun 08; 16(6):e71-7. PubMed ID: 27013181
    [Abstract] [Full Text] [Related]

  • 14. Long-term follow-up of patients with monoclonal gammopathy of undetermined significance after kidney transplantation.
    Naina HV, Harris S, Dispenzieri A, Cosio FG, Habermann TM, Stegall MD, Dean PG, Prieto M, Kyle RA, Rajkumar SV, Leung N.
    Am J Nephrol; 2012 Jun 08; 35(4):365-71. PubMed ID: 22473253
    [Abstract] [Full Text] [Related]

  • 15. Comparative evaluation of involved free light chain and monoclonal spike as markers for progression from monoclonal gammopathy of undetermined significance to multiple myeloma.
    Gran C, Liwing J, Wagner AK, Verhoek A, Gezin A, Alici E, Nahi H.
    Am J Hematol; 2021 Jan 08; 96(1):23-30. PubMed ID: 32936979
    [Abstract] [Full Text] [Related]

  • 16. Detection and prevalence of monoclonal gammopathy of undetermined significance: a study utilizing mass spectrometry-based monoclonal immunoglobulin rapid accurate mass measurement.
    Murray D, Kumar SK, Kyle RA, Dispenzieri A, Dasari S, Larson DR, Vachon C, Cerhan JR, Rajkumar SV.
    Blood Cancer J; 2019 Dec 13; 9(12):102. PubMed ID: 31836698
    [Abstract] [Full Text] [Related]

  • 17. Light chain monoclonal gammopathy of undetermined significance is characterized by a high disappearance rate and low risk of progression on longitudinal analysis.
    Pelzer BW, Arendt M, Moebus S, Eisele L, Jöckel KH, Dührsen U, Dürig J, Heinz Nixdorf Recall Study Investigative Group.
    Ann Hematol; 2018 Aug 13; 97(8):1463-1469. PubMed ID: 29629484
    [Abstract] [Full Text] [Related]

  • 18. Characteristics and prognosis of patients with non-immunoglobulin-M monoclonal gammopathy of undetermined significance: a retrospective study.
    Kuwabara C, Sakuma Y, Kume A, Tamura Y, Shimizu R, Iwai R, Ishii A, Tanaka H.
    Int J Hematol; 2019 Feb 13; 109(2):154-161. PubMed ID: 30406907
    [Abstract] [Full Text] [Related]

  • 19. Long-Term Follow-up of Monoclonal Gammopathy of Undetermined Significance.
    Kyle RA, Larson DR, Therneau TM, Dispenzieri A, Kumar S, Cerhan JR, Rajkumar SV.
    N Engl J Med; 2018 Jan 18; 378(3):241-249. PubMed ID: 29342381
    [Abstract] [Full Text] [Related]

  • 20. Association of Immune Marker Changes With Progression of Monoclonal Gammopathy of Undetermined Significance to Multiple Myeloma.
    Landgren O, Hofmann JN, McShane CM, Santo L, Hultcrantz M, Korde N, Mailankody S, Kazandjian D, Murata K, Thoren K, Ramanathan L, Dogan A, Rustad E, Lu SX, Akhlaghi T, Kristinsson SY, Björkholm M, Devlin S, Purdue MP, Pfeiffer RM, Turesson I.
    JAMA Oncol; 2019 Sep 01; 5(9):1293-1301. PubMed ID: 31318385
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.